Gustavo Vianna joins as EVP and President, Europe Dan Valenti joins as EVP, North America Doors & Distribution Matt Meier joins as EVP, Chief Digital and Information Officer CHARLOTTE, N.C., Feb. 8, 2024 /PRNewswire/ — JELD-WEN Holding, Inc. (NYSE: JELD), a leading global manufacturer of…
Month: February 2024
Gustavo Vianna joins as EVP and President, Europe Dan Valenti joins as EVP, North America Doors & Distribution Matt Meier joins as EVP, Chief Digital and Information Officer CHARLOTTE, N.C., Feb. 8, 2024 /PRNewswire/ — JELD-WEN Holding, Inc. (NYSE: JELD), a leading global manufacturer of…
-Tetra Pharm Technologies avanza el antagonista de CB1, TPT0701, para la supresión del apetito en pruebas preclínicas La empresa biofarmacéutica danesa Tetra Pharm Technologies se enorgullece de anunciar un hito importante en el ámbito de la investigación sobre la supresión del apetito al…
-Tetra Pharm Technologies avanza el antagonista de CB1, TPT0701, para la supresión del apetito en pruebas preclínicas La empresa biofarmacéutica danesa Tetra Pharm Technologies se enorgullece de anunciar un hito importante en el ámbito de la investigación sobre la supresión del apetito al…
The Danish biopharmaceutical company, Tetra Pharm Technologies, proudly announces a significant milestone in the realm of appetite suppression research having developed a cutting-edge compound leveraging their innovative platform technology. COPENHAGEN, Denmark, Feb. 8, 2024 /PRNewswire/…
The Danish biopharmaceutical company, Tetra Pharm Technologies, proudly announces a significant milestone in the realm of appetite suppression research having developed a cutting-edge compound leveraging their innovative platform technology. COPENHAGEN, Denmark, Feb. 8, 2024 /PRNewswire/…
HERPEN, The Netherlands, Feb. 8, 2024 /PRNewswire/ — Orexa B.V., a Dutch life sciences company that is developing a new medicine that increases food intake and supports health in patients, announces that the first patient has been dosed in a Phase 2 clinical trial in the prevention of…
HERPEN, The Netherlands, Feb. 8, 2024 /PRNewswire/ — Orexa B.V., a Dutch life sciences company that is developing a new medicine that increases food intake and supports health in patients, announces that the first patient has been dosed in a Phase 2 clinical trial in the prevention of…
HONGKONG, 8. února 2024 /PRNewswire/ – Před aktivací mainnetu Cancun-Deneb (neboli Dencun), nejočekávanějšího upgradu Etherea v roce 2024, popisuje společnost CoinEx jeho hlavní prvky. Proto-Danksharding, bloby, KZG: Co v sobě ukrývá Dencun Odborníci ze společnosti CoinEx popsali Dencun…
HONGKONG, 8. února 2024 /PRNewswire/ – Před aktivací mainnetu Cancun-Deneb (neboli Dencun), nejočekávanějšího upgradu Etherea v roce 2024, popisuje společnost CoinEx jeho hlavní prvky. Proto-Danksharding, bloby, KZG: Co v sobě ukrývá Dencun Odborníci ze společnosti CoinEx popsali Dencun…